Cargando…

The Role of PTEN Loss in Immune Escape, Melanoma Prognosis and Therapy Response

Checkpoint blockade therapies have changed the clinical management of metastatic melanoma patients considerably, showing survival benefits. Despite the clinical success, not all patients respond to treatment or they develop resistance. Although there are several treatment predictive biomarkers, unde...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cabrita, Rita, Mitra, Shamik, Sanna, Adriana, Ekedahl, Henrik, Lövgren, Kristina, Olsson, Håkan, Ingvar, Christian, Isaksson, Karolin, Lauss, Martin, Carneiro, Ana, Jönsson, Göran
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7140048/ https://www.ncbi.nlm.nih.gov/pubmed/32245160 http://dx.doi.org/10.3390/cancers12030742

Ejemplares similares

Analysis of DNA methylation patterns in the tumor immune microenvironment of metastatic melanoma
por: Mitra, Shamik, et al.
Publicado: (2020)

Tumor genetic heterogeneity analysis of chronic sun‐damaged melanoma
por: Sanna, Adriana, et al.
Publicado: (2019)

DNA promoter hypermethylation of melanocyte lineage genes determines melanoma phenotype
por: Sanna, Adriana, et al.
Publicado: (2022)

NF1‐mutated melanoma tumors harbor distinct clinical and biological characteristics
por: Cirenajwis, Helena, et al.
Publicado: (2017)

Participation in a Prospective Cohort Study on Melanoma did not Affect the Incidence and Mortality of the Studied Disease
por: INGVAR, Åsa, et al.
Publicado: (2020)

Multiple Primary Melanoma Incidence Trends Over Five Decades: A Nationwide Population-Based Study
por: Helgadottir, Hildur, et al.
Publicado: (2020)

Molecular stratification of metastatic melanoma using gene expression profiling : Prediction of survival outcome and benefit from molecular targeted therapy
por: Cirenajwis, Helena, et al.
Publicado: (2015)

Improved survival prognostication of node-positive malignant melanoma patients utilizing shotgun proteomics guided by histopathological characterization and genomic data
por: Betancourt, Lazaro Hiram, et al.
Publicado: (2019)

Molecular and genetic diversity in the metastatic process of melanoma
por: Harbst, Katja, et al.
Publicado: (2014)

High risk of tobacco-related cancers in CDKN2A mutation-positive melanoma families
por: Helgadottir, Hildur, et al.
Publicado: (2014)

Mutational and putative neoantigen load predict clinical benefit of adoptive T cell therapy in melanoma
por: Lauss, Martin, et al.
Publicado: (2017)

Author Correction: Mutational and putative neoantigen load predict clinical benefit of adoptive T cell therapy in melanoma
por: Lauss, Martin, et al.
Publicado: (2020)

Establishing a Southern Swedish Malignant Melanoma OMICS and biobank clinical capability
por: Welinder, Charlotte, et al.
Publicado: (2013)

Efficacy of novel immunotherapy regimens in patients with metastatic melanoma with germline CDKN2A mutations
por: Helgadottir, Hildur, et al.
Publicado: (2020)

Risk of malignant melanoma in relation to drug intake, alcohol, smoking and hormonal factors.
por: Westerdahl, J., et al.
Publicado: (1996)

Risk of cutaneous malignant melanoma in relation to use of sunbeds: further evidence for UV-A carcinogenicity
por: Westerdahl, J, et al.
Publicado: (2000)

DNA methylation subgroups in melanoma are associated with proliferative and immunological processes
por: Lauss, Martin, et al.
Publicado: (2015)

Correlation of histopathologic characteristics to protein expression and function in malignant melanoma
por: Welinder, Charlotte, et al.
Publicado: (2017)

Prognostic Significance of Sentinel Lymph Node Status in Thick Primary Melanomas (> 4 mm)
por: Holmberg, Carl-Jacob, et al.
Publicado: (2023)

Analysis of Alpha-Synuclein in Malignant Melanoma – Development of a SRM Quantification Assay
por: Welinder, Charlotte, et al.
Publicado: (2014)

A Population-Based Comparison of the AJCC 7th and AJCC 8th Editions for Patients Diagnosed with Stage III Cutaneous Malignant Melanoma in Sweden
por: Isaksson, Karolin, et al.
Publicado: (2019)

A Protein Deep Sequencing Evaluation of Metastatic Melanoma Tissues
por: Welinder, Charlotte, et al.
Publicado: (2015)

Loss of CITED1, an MITF regulator, drives a phenotype switch in vitro and can predict clinical outcome in primary melanoma tumours
por: Howlin, Jillian, et al.
Publicado: (2015)

B Cells and Tertiary Lymphoid Structures: Friends or Foes in Cancer Immunotherapy?
por: Lauss, Martin, et al.
Publicado: (2022)

Escape from nonsense-mediated decay associates with anti-tumor immunogenicity
por: Litchfield, Kevin, et al.
Publicado: (2020)

Low-grade inflammation in survivors of childhood cancer and testicular cancer and its association with hypogonadism and metabolic risk factors
por: Ekedahl, Henrik, et al.
Publicado: (2022)

PTEN Methylation Dependent Sinonasal Mucosal Melanoma
por: Lee, Sang Hee, et al.
Publicado: (2016)

The Influence of Tumor Microenvironment on Immune Escape of Melanoma
por: Simiczyjew, Aleksandra, et al.
Publicado: (2020)

PTENP1-AS contributes to BRAF inhibitor resistance and is associated with adverse clinical outcome in stage III melanoma
por: Vidarsdottir, Linda, et al.
Publicado: (2021)

Novel functional proteins coded by the human genome discovered in metastases of melanoma patients
por: Sanchez, Aniel, et al.
Publicado: (2019)

C-Jun drives melanoma progression in PTEN wild type melanoma cells
por: Kappelmann-Fenzl, Melanie, et al.
Publicado: (2019)

PTEN/MMAC1 expression in melanoma resection specimens
por: Deichmann, M, et al.
Publicado: (2002)

Monitoring of Technical Variation in Quantitative High-Throughput Datasets
por: Lauss, Martin, et al.
Publicado: (2013)

MITF induces escape from innate immunity in melanoma
por: Sánchez-del-Campo, Luis, et al.
Publicado: (2021)

Increasing preoperative body size in breast cancer patients between 2002 and 2016: implications for prognosis
por: Wisse, Agatha, et al.
Publicado: (2018)

Trend Shifts in Age-Specific Incidence for In Situ and Invasive Cutaneous Melanoma in Sweden
por: Eriksson, Hanna, et al.
Publicado: (2021)

Analysis of and prognostic information from disseminated tumour cells in bone marrow in primary breast cancer: a prospective observational study
por: Falck, Anna-Karin, et al.
Publicado: (2012)

Endogenous expression mapping of malignant melanoma by mass spectrometry imaging
por: Sugihara, Yutaka, et al.
Publicado: (2018)

Cooperative interactions of PTEN deficiency and RAS activation in melanoma metastasis
por: Nogueira, Cristina, et al.
Publicado: (2010)

PERK mediates resistance to BRAF inhibition in melanoma with impaired PTEN
por: Qin, Yifei, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_nqtcr55gl3imua93jcohvqov2r